Stock Research for CCXI

CCXI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CCXI Stock Chart & Research Data

The CCXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CCXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CCXI Due diligence Resources & Stock Charts

The CCXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CCXI Detailed Price Forecast - CNN Money CNN View CCXI Detailed Summary - Google Finance
Yahoo View CCXI Detailed Summary - Yahoo! Finance Zacks View CCXI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CCXI Trends & Analysis - Trade-Ideas Barrons View CCXI Major Holders - Barrons
NASDAQ View CCXI Call Transcripts - NASDAQ Seeking View CCXI Breaking News & Analysis - Seeking Alpha
Spotlight View CCXI Annual Report - CompanySpotlight.com OTC Report View CCXI OTC Short Report - OTCShortReport.com
TradeKing View CCXI Fundamentals - TradeKing Charts View CCXI SEC Filings - Bar Chart
WSJ View Historical Prices for CCXI - The WSJ Morningstar View Performance/Total Return for CCXI - Morningstar
MarketWatch View the Analyst Estimates for CCXI - MarketWatch CNBC View the Earnings History for CCXI - CNBC
StockMarketWatch View the CCXI Earnings - StockMarketWatch MacroAxis View CCXI Buy or Sell Recommendations - MacroAxis
Bullish View the CCXI Bullish Patterns - American Bulls Short Pains View CCXI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CCXI Stock Mentions - StockTwits PennyStocks View CCXI Stock Mentions - PennyStockTweets
Twitter View CCXI Stock Mentions - Twitter Invest Hub View CCXI Investment Forum News - Investor Hub
Yahoo View CCXI Stock Mentions - Yahoo! Message Board Seeking Alpha View CCXI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CCXI - SECform4.com Insider Cow View Insider Transactions for CCXI - Insider Cow
CNBC View CCXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CCXI - OTC Markets
Yahoo View Insider Transactions for CCXI - Yahoo! Finance NASDAQ View Institutional Holdings for CCXI - NASDAQ


Stock Charts

FinViz View CCXI Stock Insight & Charts - FinViz.com StockCharts View CCXI Investment Charts - StockCharts.com
BarChart View CCXI Stock Overview & Charts - BarChart Trading View View CCXI User Generated Charts - Trading View




Latest Financial News for CCXI


J&J (JNJ) to Pay $4.69 Billion to Some Women in Talc Lawsuit
Posted on Friday July 13, 2018

Johnson & Johnson (JNJ) has been ordered to pay $4.69 billion in damages to 22 families who alleged that the company's baby powder contained asbestos that caused them to develop ovarian cancer.


Bristol-Myers' Combo Drugs Get FDA Nod for Colorectal Cancer
Posted on Thursday July 12, 2018

Bristol-Myers' (BMY) Opdivo in combination with its Yervoy received the FDA approval to treat patients with metastatic colorectal cancer (mCRC) that has progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.


KemPharm Stock Down Despite Positive Data on ADHD Candidate
Posted on Tuesday July 10, 2018

KemPharm (KMPH) presents positive top-line results on ADHD candidate KP415, which meets both primary and secondary endpoints in a pivotal study.


Jazz Sells Pain Drug Prialt's Rights to TerSera Therapeutics
Posted on Monday July 02, 2018

Jazz Pharmaceuticals (JAZZ) signs a definitive contract to sell its Prialt rights to TerSera Therapeutics for a settled amount of $80 million in cash upon its closure.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.